PMID: 1200722Dec 1, 1975Paper

Human pesticide poisonings by a fat-soluble organophosphate insecticide

Archives of Environmental Health
J E DaviesC Vaclavek

Abstract

In five cases of dichlofenthion poisoning due to suicidal ingestions, unusual toxicologic features were encountered. Initial symptoms were mild or delayed and severe cholinergic crises did not appear until 40 to 48 hours after ingestion. Two patients died, and in the three survivors, cholinesterase symptoms persisted for five to 48 days. An almost total inhibiton of both cholinesterase enzymes continued in one patient for 66 days, and prolonged antidotal therapy was required. Residues of the intact pesticide were detected in fat after 54 days in one patient, and in the blood for 75 days in another patient. The partition coefficient of dichlofenthion in fat was 20 times greater than parathion, and exceeded only by leptophos. Considering the chemical and toxicologic properties of this compound, we postulated that the mechanism of protracted intoxication is a slow release from adipose reservoirs.

References

Jan 1, 1971·Bulletin of Environmental Contamination and Toxicology·M T ShafikH F Enos
Apr 1, 1974·Bulletin of Environmental Contamination and Toxicology·J J Domanski, F E Guthrie
Aug 1, 1974·Archives of Environmental Health·J H HolmesR C Hanisch
Jan 1, 1969·Annals of the New York Academy of Sciences·J H DavisA J Fisk
Nov 1, 1966·Archives of Environmental Health·J H Holmes, L Jankowsky
Jan 1, 1966·Life Sciences·W E DaleC Cueto
Oct 1, 1961·The Journal of Clinical Endocrinology and Metabolism·A G FRANTZJ W JAILER
Dec 1, 1964·Metabolism: Clinical and Experimental·E E WERKL J SHOLITON

❮ Previous
Next ❯

Citations

Dec 1, 1985·Archives of Toxicology·J Martinez Chuecos, J Sole Violan
Nov 1, 1986·Archives of Environmental Contamination and Toxicology·N KonnoM Fukushima
Nov 1, 1979·Bulletin of Environmental Contamination and Toxicology·H C Hollifield
Jan 15, 1979·Experientia·N Konno, H Kinebuchi
Jan 15, 1980·Experientia·T YamauchiH Kinebuchi
Oct 1, 1996·Environmental Health and Preventive Medicine·S YamanakaY Takaesu
Jan 1, 1992·Clinical Neurology and Neurosurgery·J L De BleeckerJ L Willems
Feb 1, 1988·The Journal of Pediatrics·S M Borowitz
Sep 7, 2001·Toxicology·M Jokanović
Dec 5, 2003·The Journal of Emergency Medicine·Jason E MattinglyGeorge M Bosse
Jun 10, 2000·The Journal of Emergency Medicine·A A Karcic
Mar 6, 2008·QJM : Monthly Journal of the Association of Physicians·J O J DaviesN A Buckley
Oct 1, 1992·Acta Neurologica Scandinavica·J De BleeckerJ De Reuck
Jun 1, 1979·Environmental Health Perspectives·V H FreedR Kohnert
May 27, 2014·The American Journal of Emergency Medicine·Duk Hee LeeYoung Jin Cheon
Nov 27, 2014·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·John Victor PeterJohn L Moran
Dec 3, 2014·Emergency Medicine Clinics of North America·Andrew M King, Cynthia K Aaron
Jan 7, 2016·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Kent K RejiJohn Victor Peter
Jan 1, 1992·Journal of Toxicology. Clinical Toxicology·J De BleeckerJ Willems
Jan 1, 1992·Journal of Toxicology. Clinical Toxicology·J De BleeckerD Vogelaers
Jan 1, 1994·Journal of Toxicology. Clinical Toxicology·N A BuckleyI M Whyte
Jan 1, 1995·Journal of Toxicology. Clinical Toxicology·K FutagamiR Oishi
Mar 5, 2011·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Alexis SoummerJean-Jacques Rouby
Dec 20, 2011·Toxicology and Applied Pharmacology·Mohammad Abdollahi, Somayyeh Karami-Mohajeri
Aug 24, 2011·Journal of Applied Toxicology : JAT·Yossi RosmanYael Mardor
Jul 1, 1990·Toxicology and Applied Pharmacology·B VeronesiC Pope
Sep 20, 2005·Critical Care Clinics·Claudia L Barthold, Joshua G Schier
Nov 25, 2014·American Journal of Respiratory and Critical Care Medicine·Elspeth J HulseMichael Eddleston
Aug 1, 1978·Toxicology and Applied Pharmacology·N Konno, H Kinebuchi
Sep 15, 1989·Toxicology and Applied Pharmacology·N KonnoM Fukushima
Feb 19, 2008·Lancet·John Victor PeterKishore Pichamuthu
Jan 1, 1990·Human & Experimental Toxicology·D JovanovićD Joksović
Sep 1, 1987·Human Toxicology·M YoshidaS Owada
Oct 1, 1995·Environmental Health Perspectives·M S Wolff, P G Toniolo
Sep 20, 2018·Annual Review of Pharmacology and Toxicology·Michael Eddleston
Sep 1, 1977·Archives of Environmental Health·R A WarrinerW J Hayes

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.